INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT

Similar documents
INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT

DRAFT DRAFT. Paediatric Antibiotic Prescribing Guideline. May

GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

Author s: Clinical Standards Group and Effectiveness Sub-Board

Infection Comments First Line Agents Penicillin Allergy History of multiresistant. line treatment: persist for >7 days they may be

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)

Volume. December Infection. Notes. length of. cases as 90% 1 week. tonsillitis. First Line. sore throat / daily for 5 days. quinsy >4000.

Paediatric Empirical Antimicrobial Guidance for Infections in Hospital

Guidelines for Antimicrobial treatment for treatment of confirmed infections adults

Rational management of community acquired infections

Antimicrobial Update Stewardship in Primary Care. Clare Colligan Antimicrobial Pharmacist NHS Forth Valley

Volume 1; Number 7 November 2007

your hospitals, your health, our priority PARC (Policy Approval and Ratification Committee) STANDARD OPERATING PROCEDURE:

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

Women s Antimicrobial Guidelines Summary

Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS

Prescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children

Volume 2; Number 16 October 2008

Approach to pediatric Antibiotics

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

MANAGEMENT OF INFECTION GUIDANCE FOR PRIMARY CARE PRESCRIBERS IN NORTHAMPTONSHIRE

Antibiotic Guidelines

Advanced Practice Education Associates. Antibiotics

Septicaemia Definitions 1

GASTRO-INTESTINAL TRACT INFECTIONS - ANTIMICROBIAL MANAGEMENT

Guidelines for the Empirical Treatment of Sepsis in Adults (excluding Neutropenic Sepsis)

SURGICAL ANTIBIOTIC PROPHYLAXIS GUIDELINES WITHIN ORTHOPAEDIC SURGERY FOR ADULT PATIENTS

Intro Who should read this document 2 Key practice points 2 Background 2

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally

GUIDELINE FOR ANTIMICROBIAL USE IN THE ORTHOPAEDIC AND TRAUMA DEPARTMENT

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

Prepared: August Review: July Common Infections. A Medicines Optimisation Antibiotic Prescribing Guide.

moxifloxacin intravenous, 400mg/250mL, solution for infusion (Avelox ) SMC No. (650/10) Bayer Schering

Who should read this document 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version 3. Policy/Procedure/Guideline 3

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

National Antimicrobial Prescribing Survey

Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.

Pneumonia Antibiotic Guidance for Adults PAGL Inclusion Approved at January 2017 PGC

Acute Pyelonephritis POAC Guideline

Section 6.2 Antibacterials including Access, Watch and Reserve Lists of antibiotics

Cephalosporins, Quinolones and Co-amoxiclav Prescribing Audit

Rational use of antibiotic in upper respiratory tract infection (URI) and community acquired pneumonia รศ.จามร ธ รตก ลพ ศาล 23 พฤษภาคม 2550

Update on Fluoroquinolones. Charles Krasner, M.D. June 16, 2016 Antibiotic Stewardship Program -ECHO

ANTIBIOTIC FORMULARY AND PRESCRIBING ADVICE FOR PAEDIATRIC PATIENTS OTHER THAN NEONATES

Protocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CONTROLLED DOCUMENT

1 East Cheshire NHS Trust Paediatric Antibiotic Policy V 2.1 June 17 Review June 18

Who should read this document? 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version? 3

Diabetic Foot Infection. Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals

Aminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.

Central Nervous System Infections

Empirical Management of Infection on Critical Care Units at AUH and RLUH

Antibiotic Guidelines

** the doctor start the lecture with revising some information from the last one:

ANTIBIOTIC GUIDELINES Adult and Paediatric

ECHO: Management of URIs. Charles Krasner, M.D. Sierra NV Veterans Affairs Hospital University of NV, Reno School of Medicine October 16, 2018

Symptoms of cellulitis (n=396) %

Updated recommended treatment regimens for gonococcal infections and associated conditions United States, April 2007

Antimicrobial susceptibility

Community Acquired Pneumonia (CAP)

Antibiotic Updates: Part II

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Delayed Prescribing for Minor Infections Resource Pack for Prescribers

References and supporting documents 5 Roles and responsibilities 5

GUIDELINES FOR IV TO ORAL SWITCH FOR ANTIBITOICS

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

Antimicrobial Stewardship in Ambulatory Care

EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia

Antibiotic Usage Guidelines in Hospital

FOLLOWING BUNDLE ADMINISTERED WITHIN ONE HOUR.

Trust Guideline for the Management of: Antibiotic Prophylaxis in adults undergoing procedures in Interventional Radiology

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

Pharmacology Week 6 ANTIMICROBIAL AGENTS

Report on Point Prevalence Survey of Antibacterial Prescribing at Ysbyty Gwynedd Hospital November 2008

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Empiric Treatment of Sepsis. Professor of Clinical Microbiology Department of Microbiology Leicester University U. K.

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust

This letter authorises the extended use of the following guidance until 1st December 2018:

CLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met:

NEONATAL Point Prevalence Survey. Ward Form

number Done by Corrected by Doctor Dr.Malik

Content. In the beginning Antimicrobial Stewardship 2. Antimicrobial Prescribing with cases to cover

Adult Antibiotic Guidelines. Secondary Care

All prescribers, charge nurses, clinical pharmacists. NHS Borders Antimicrobial Management Team

Responsible use of antibiotics

Neurosurgery Antibiotic Prophylaxis Guideline

- the details, where possible, of the antibiotic products these companies supply or have supplied.

NHS The NHS in Rotherham ANTIMICROBIAL SUMMARY PROTOCOL FOR THE MANAGEMENT OF INFECTION IN PRIMARY CARE Next review due December 2019

Antimicrobial Paediatric Guidelines NWPAIIG. North West Paediatric Allergy, Immunology and Infection Group Operation Delivery Network (NWPAIIG)

Clinical Guideline. District Infectious Diseases Management. Go to Guideline. District Infectious Diseases Management CG 18_24

SECTION 3A. Section 3A Criteria for Optional Special Authorization of Select Drug Products

Update on current SAPG projects

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija

ANTIBIOTIC PRESCRIBING POLICY FOR DIABETIC FOOT DISEASE IN SECONDARY CARE

Transcription:

INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT Name & Title Of Authors: Dr M Milupi, Consultant Microbiologist Dr N Rao,Consultant Paediatrician Dr V Desai Consultant Paediatrician Date Revised: APRIL 2018 Approved by Committee/Group: AMT / DTC Date Of Approval: MAY 2018 Date Issued: OCTOBER 2018 Next review date: MAY 2020 WARNING: Always ensure that you are using the most up to date policy or procedural document. If you are unsure, you can check that it is the most up to date version by looking on the Trust Website: www.dbth.nhs.uk 1

CONTENTS Section Title 1 Introduction 2 Gastrointestinal Infections 3 Upper Respiratory Tract Infections 4 Lower Respiratory Tract Infections 5 Skin Infections 6 Urinary Tract Infections 7 Eye Infections 8 Bone and Joint Infections 9 Central Nervous System Infections AND Sepsis of Unknown Origin 2

1. Introduction Dosing information is available in the most recent edition of BNF for Children NOTE: IN THE CASE OF SEVERE INFECTIONS USE THE HIGHEST RECOMMENDED DOSE Unless otherwise stated, the duration of treatment for most of the uncomplicated infections with no serious underlying disease is 5-7 days. In serious infections, the duration will be determined by the patient s condition and response to treatment Empiric antimicrobial treatment for conditions not listed below should be discussed with the microbiologist For more detailed information regarding causative organisms and microbiological investigations, please refer to the equivalent Adult Antimicrobial guidelines This guidance does not cover antibiotic treatment of Haemato-oncology patients, patients with Tuberculosis or Cystic fibrosis and neonates. Please refer to separate guidelines All antimicrobial treatments should be revised based on clinical response or as soon as culture results are available. Please ensure that vital information about the patient (eg clinical findings, radiological/biochemical results, antibiotic history etc) is available to hand before contacting microbiologists 3

2. Gastrointestinal Infections Type of Infection Antibacterial agent Oral switch when clinically indicated Comments IV Co-amoxiclav Co-amoxiclav Peritonitis Second line Non life-threatening penicillin allergy penicillin allergy IV Cefuroxime AND IV Metronidazole IV/oral Ciprofloxacin AND IV/oral Metronidazole Cefalexin AND Metronidazole Ciprofloxacin AND Metronidazole Length of treatment depends on clinical condition but generally 5-7 days. Antibiotics should be modified based on sensitivity results. Salmonellosis and Shigellosis Campylobacter enteritis Escherichia coli 0157 Only treat with antibiotics in the following: Salmonella typhoid fever or invasive salmonellosis immunosuppression cardiac valves or endovascular abnormalities <3 months of age Haemoglobinopathies Chronic GI illnesses Campylobacter or Shigella severe symptoms systemically unwell immunosuppression or prolonged symptoms of > 1 week(for Campylobacter) consider antibiotics if admitted to hospital or attends day care(for Shigella) Non-invasive disease is usually self- limiting Do not treat with antibiotics, as this may lead to an increase in toxin release. If antibiotic treatment is required, consult Microbiologist Notifiable disease May lead to haemolytic-uraemic syndrome (HUS). This is a Notifiable disease C.difficile infection Refer to the trust C.difficile policy PAT/IC 26. Use BNF for children for dosage information. Presence of Clostridium difficile toxin is not usually clinically significant in children under 2 years old. 4

3. Upper Respiratory Tract Infections Type of Infection Antibacterial agent If MRSA positive add: Oral switch Comments Acute Epiglottitis penicillin/ cephalosporin allergy IV Cefotaxime IV Ceftriaxone IV Co-trimoxazole Oral/IV clarithromycin (if susceptible) Oral/IV Linezolid (if clarithromycin resistant) Full course IV preferable If oral switch possible: Co-amoxiclav Co-trimoxazole (if ) AND oral MRSA cover where indicated. Secure airway Length of treatment depends on clinical condition but minimum 10 days. Base oral switch on sensitivity results where available. Viral Viruses are common causes for which antibiotics are not indicated Oral/IV Amoxicillin Acute Otitis Media Penicillin allergy penicillin allergy AND clari/azithro contra-indicated. Recurrent infection or failure of 48hrs of Amoxicillin: Oral/IV Co-amoxiclav Oral/ IV Clarithromycin Oral Azithromycin (>6 months of age) Recurrent infection or failure of 48hrs second line: IV Cefuroxime or oral Cefaclor (Avoid in patients with penicillin anaphylaxis) Discuss with Microbiology Oral/IV clarithromycin (if susceptible and not already on) Oral Linezolid (unless susceptible to clarithromycin/azithromycin and patient is on this regime) As for first/second line oral choice +/- MRSA cover where indicated Antibiotics other than Azithromycin Treat for 7 days if 2yrs old Treat for 10 days if <2yrs and / or has old/recurrent disease Azithromycin Used Treat for 3 days 5

Sinusitis Penicillin allergy Oral or IV Amoxicillin Failure of 48hrs of Amoxicillin: Oral/IV Co-amoxiclav Oral/IV Clarithromycin Oral Azithromycin (>6 months of age) Failure of 48hrs second line: IV Cefuroxime or oral Cefaclor (Avoid in patients with penicillin anaphylaxis) Oral/IV clarithromycin (if susceptible and not already on) Oral/IV Linezolid (unless susceptible to clarithromycin/azithromycin and patient is on this regime) As for first/second line oral choice +/- MRSA cover where indicated For Azithromycin, treat for 3 days. Otherwise treat for 7 days penicillin allergy AND clari/azithro contra-indicated. Discuss with the Microbiologist Tonsillitis/ Pharyngitis Second line/penicillin allergy Oral Phenoxymethylpenicillin (Penicillin V) IV Benzylpenicillin (if cannot take orally) Oral/IV Clarithromycin Oral Azithromycin (>6 months of age) Oral/IV clarithromycin (if susceptible and not already on) Ora/IV Linezolid (unless susceptible to clarithromycin/azithromycin and patient is on this regime) For Azithromycin, treat for 3 days. Otherwise, treat for 10 days Pertussis Second line/penicillin allergy IV or Oral Clarithromycin Oral Azithromycin (>6 months of age) IV or oral Co-trimoxazole Clarithromycin Azithromycin Co-trimoxazole Azithromycin: treat for 3 days. Otherwise treat for 7 days Commence treatment within 21 days of onset. Notifiable disease 6

4. Lower Respiratory Tract Infections Type of Infection Antibacterial agent If MRSA positive add: Oral switch Comments Oral Amoxicillin Oral Typical Pneumonia Mild - moderate Severe i.e. Fever 39 C Toxicity Cough + SOB + grunting + chest pain Unilateral creps + bronchial breathing CXR lobar consolidation penicillin allergy or cephalosporin allergy AND 2nd line contra-indicated Oral Clarithromycin Oral Azithromycin (>6 months of age) Discuss with the Microbiologist IV Amoxicillin +/- Flucloxacillin (if < 2 years old) Add in IV Clarithromycin if:- suspected mycoplasma or Chlamydophila and/or no response after 48 hrs IV Clarithromycin Clarithromycin (if susceptible) Add Oral Linezolid to Amoxicillin (if Clarithromycin resistant) IV/oral Clarithromycin IV/oral Linezolid (unless susceptible to clarithromycin and patient is on this) N/A Clarithromycin Azithromycin (>6 months of age) +/- amoxicillin +/- linezolid (if indicated for MRSA) Clarithromycin Azithromycin (>6 months of age) monotherapy +/- linezolid (if indicated for MRSA) Viruses account for a significant number of cases of Community Acquired Pneumonia in children and antibiotics may not be indicated Length of treatment depends on clinical condition but generally 3 days for Azithromycin and 5-7 days for other antibiotics for typical pneumonia. Please discuss with microbiologist for atypical pneumonia Discuss with microbiologist if no response after 48hrs of treatment. If no better in 72hrs, consider empyema and manage as below 7

Type of Infection Antibacterial agent If MRSA positive add: Oral switch Comments Atypical Pneumonia i.e. Cough + sore throat, rash CXR Bilateral interstitial shadows Pneumonia associated with or after significant viral illness such as Influenza, Measles or Chickenpox. penicillin allergy IV/ Oral Clarithromycin Oral Azithromycin (>6 months of age) Discuss with Microbiologist IV Co-amoxiclav IV Cefuroxime Contact Microbiologist for IV and oral option IV or oral Linezolid (unless already on clarithromycin or azithromycin AND MRSA is susceptible) IV or oral Clarithromycin (if susceptible) IV or oral Linezolid (if clarithromycin resistant) As for 1 st or 2 nd line (Discuss with Microbiologist if 1 st or 2 nd line not available orally) Same as IV except for cefuroxime, in which case use Cefaclor. Viruses account for a significant number of cases of Community Acquired Pneumonia in children and antibiotics may not be indicated Length of treatment depends on clinical condition but generally 3 days for Azithromycin and 5-7 days for other antibiotics for typical pneumonia. Please discuss with microbiologist for atypical pneumonia Discuss with microbiologist if no response after 48hrs of treatment. If no better in 72hrs, consider empyema and manage as below Empyema Refer to adult guideline For dosage information, use BNF for children. Seek specialist advice from Paediatric Respiratory team and Microbiologist. 8

5. Skin Infections Type of Infection Antibacterial agent Oral switch Comments Oral Flucloxacillin Treat for 5-7 days or until Oral Clarithromycin resolution whichever is later Cellulitis - MILD MRSA positive (if sensitive) If MRSA positive and resistant to above: Oral Clindamycin (if intolerant to Clarithromycin) Oral Linezolid N/A Severe or Streptococcal infection: Add Amoxicillin to Flucloxacillin if no Cellulitis MODERATE / SEVERE Impetigo Wound infection Infected eczema MRSA positive (if sensitive) If MRSA positive and resistant to above IV or oral Flucloxacillin IV or oral Clarithromycin IV or oral Clindamycin (if intolerant to Clarithromycin) IV or oral Linezolid Same as IV option improvement after 48hrs Severe infection may require IV therapy Human / Animal Bites (established infection) For severe infections Second line/ MRSA positive (if sensitive) IV or oral Co-amoxiclav If MRSA positive add: IV Linezolid IV Cefotaxime AND IV Metronidazole If MRSA positive add: IV Linezolid IV or oral Clindamycin AND IV or Oral Ciprofloxacin As for 1 st line N/A Same as IV option Cleanse wound and consider tetanus toxoid Assess hepatitis B & C, HIV & rabies risk. Treat for 10-14 days If MRSA positive and resistant to above: IV or oral Linezolid 9

6. Urinary Tract Infections (Please refer to NICE guidance regarding further investigations) Type of Infection Antibacterial agent Antibacterial agent Oral switch Comments Suspected UTI AND LESS than 3 months old IV Cefotaxime AND IV Amoxicillin Please discuss with Microbiologist N/A Duration of treatment should be discussed with microbiologist if likely to last more than 7 days. Lower urinary tract infection (cystitis i.e. no systemic signs and symptoms) AND 3 ME months old Oral Nitrofurantoin (If unable to swallow tablets use second line) Oral Cefalexin If recent culture with sensitive organism, use: Oral Trimethoprim Oral Amoxicillin If life threatening penicillin allergy/cephalosporin allergy and 1 st and 2 nd line contra-indicated, please contact Microbiologist Trimethoprim Cefalexin Nitrofurantoin Amoxicillin (based on sensitivities) Total Duration of treatment IV + Oral : Cystitis - 3 days Pyelonephritis - 10 days Upper urinary tract infection (pyelonephritis) AND THREE ME months old IV Cefuroxime If life threatening penicillin allergy/cephalosporin allergy: IV or oral Ciprofloxacin Based on sensitivities but avoid Nitrofurantoin 10

7. Eye Infections Type of Infection Antibacterial agent Oral switch Comments Ophthalmia Neonatorum 1.Chlamydial conjunctivitis 2. Gonococcal conjunctivitis Oral Clarithromycin AND single IV Ceftriaxone dose (see BNFc) Discuss with microbiologist. N/A Treat for 14 days Contact tracing mandatory Discussion with the Ophthalmologist is essential. Most cases of mild conjunctivitis are allergic or viral in origin and do not require antibiotics. Continue antibiotics for 48 hrs after eyes are clear. Severe bacterial conjunctivitis Chloramphenicol 0.5% eye drops or 1% ointment Levofloxacin eye drops (avoid in < 1 yr old) Azithromycin eye drops Fusidic acid 1% eye drops (only in suspected staphylococcal N/A Ensure correct eye swabs are taken for Chlamydia and gonococcus. Treatment should be adjusted based on sensitivity results conjunctivitis) 11

Type of Infection Antibacterial agent MRSA positive Oral switch Comments Mild Oral Flucloxacillin Use: Oral Linezolid Peri-orbital cellulitis Moderate-severe periorbital cellulitis: IV Co-amoxiclav Add: IV Linezolid Discuss with microbiologist if penicillin allergic or no response after 48hrs of treatment Discuss with microbiologist Consider nasal decongestant drops. Arrange ENT and Ophthalmology review within 24 hours of admission. Length of IV treatment depends on patients condition. Orbital cellulitis IV Cefotaxime AND IV Metronidazole Add: IV Linezolid 12

8. Bone and Joint Infections Please refer to the Adult Orthopaedic and Trauma guidelines for further information Type of Infection Osteomyelitis/ Septic Arthritis (>5 yrs) Osteomyelitis/ Septic Arthritis ( 3 months 5yrs) Antibacterial agent Life threatening penicillin allergy/ cephalosporin allergy: Antibacterial agent MRSA positive Oral switch Comments IV Flucloxacillin IV Clindamycin IV Cefuroxime IV or oral Ciprofloxacin AND IV Teicoplanin (check MRSA results if indicated) Use: IV Clindamycin (if susceptible) IV Teicoplanin (if clindamycin resistant) Add: IV Teicoplanin (based on sensitivity results) Same as IV option If MRSA positive: Discuss with Microbiologist First line: Co-amoxiclav Second line: Clindamycin If MRSA positive resistant to Clindamycin: Discuss with the Microbiologist Full intravenous course may be required. For duration of treatment, please refer to the Trust Orthopaedic and Trauma antibiotic guidelines Discuss with Consultant Microbiologist Osteomyelitis/ Septic Arthritis (<3months old) First line IV Cefotaxime AND IV Amoxicillin Add: IV Teicoplanin (based on sensitivity results) As in suspected sepsis or meningitis. Seek specialist advice from Orthopaedics & Microbiology First line IV Co-amoxiclav Co-amoxiclav Compound fracture (A&E initial therapy) (mild) penicillin allergy/cephalosp orin allergy IV Cefuroxime AND IV Metronidazole IV or oral Ciprofloxacin AND IV or oral Metronidazole AND IV Teicoplanin 13 Add: IV Teicoplanin if not already on this (based on sensitivity results) Cefalexin AND Metronidazole Discuss with Microbiologist If MRSA positive: Discuss with Microbiologist Review need for continuing therapy as advised by Consultant orthopaedic surgeon.

9. Central Nervous System Infections and / or suspected sepsis of unknown origin NOTE: AS IN BNFC F SEVERE INFECTION USE HIGHEST RECOMMENDED DOSE Type of Infection Antibacterial agent Comments Bacterial Meningitis Meningococcal sepsis THREE ME months old Neonatal meningitis/ sepsis Up to THREE months old penicillin allergy/ cephalosporin allergy penicillin allergy/ cephalosporin allergy IV Cefotaxime [The dose for severe infection is 50mg/kg FOUR times a day (maximum 12 grams per day)] IV Ceftriaxone [The dose for severe infection is 80mg/kg (maximum FOUR grams) once a day)] IV Chloramphenicol IV Cefotaxime AND IV Amoxicillin Discuss with Microbiologist Please discuss with the Microbiologist regarding the specific antibiotic to be used for a specific organism, including if MRSA colonised. Please notify Public Health. Full course of parenteral therapy. Oral switch not recommended - discuss with Microbiologist. Duration of treatment: Meningococcal 7 days H.influenzae 10 days Pneumococcal 14 days Group B Streptococcus at least 14 days Gram negative organisms at least 21 days Listeria 21 days in total and at least 7 days of Gentamicin Unconfirmed organism: 14 days for children LESS THAN THREE months old 10days for children THREE ME months old Consider stopping antibiotics if CSF PCRs (FilmArray) is negative or switching to a more narrow spectrum agent based on the relevant source of sepsis Viral encephalitis IV Aciclovir USE CRECT HIGH DOSE AS IN BNFC Contact virologist at NGH (Sheffield) Treat for at least 21 days. Liaise with the virologist at NGH (Sheffield) 14